Guacamole Recall Update as FDA Sets Highest Risk Level
The guacamole, peppers, and vegetables voluntarily recalled by the maker have been classed as the highest risk level by the ...
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...
Eat first, test later: How the FDA’s food regulatory system is broken
A regulatory loophole allows manufacturers to add untested ingredients to food that are later found to be dangerous. Here’s ...
US FDA says Lilly's weight-loss drug no longer in shortage
Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...
CDC warns against potentially counterfeit meds sold by online pharmacies
The search for more affordable medications might cause people to access dangerous counterfeit drugs sold as genuine products ...
FDA Recalls Gluten-Free Cake and Gives Risk Classification
The "mini raspberry lemon coffee cake" was recalled due to potentially containing undeclared wheat flour and walnuts.
FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
Medscape1d
FDA Approves Ustekinumab Biosimilar Otulfi
Ustekinumab-aauz is Fresenius Kabi's fourth biosimilar granted US approval, behind adalimumab-aacf (Idacio), tocilizumab-aazg ...
Medscape2d
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...
MedPage Today1d
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D
The FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
Targeted Oncology17m
FDA Approves Perioperative Nivolumab in Resectable NSCLC
The FDA has approved nivolumab plus chemotherapy as a neoadjuvant treatment for operable stage IIA to IIIB non–small cell ...